Janchor Partners is a long-term fundamental investor with an "Industrialist Investor" mindset, primarily focusing on companies with significant exposure to the Pan-Asian region. Their strategy involves deep fundamental research, constructing a concentrated portfolio of high-quality investments, and building lasting relationships with investee companies to enhance long-term corporate value.
67% of their portfolio is in Biotech & Life Sciences.
Portfolio
3
Fund Size
$4B
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
3 investments
Top Co-Investors
Lilly Asia Ventures1 shared
Lake Bleu Capital1 shared
Vivo Capital1 shared
OrbiMed1 shared
Hudson Bay Capital1 shared
Loyal Valley Capital1 shared
RA Capital Management1 shared
Hillhouse Capital1 shared
Decheng1 shared
Janus Henderson Investors1 shared
Rock Springs Capital1 shared
Cormorant Asset Management1 shared
Pavilion Capital1 shared
HBM Healthcare Investment1 shared
Tiger Global Management1 shared
Square Peg Capital1 shared
Last updated: 16 April 2026